Physician profile
Jasdeep Dalawari
NPI 1215986807
$4,281.11
in general payments reported to CMS, 2019-2025
23 companies · $1,350 in 2025
The $1,350 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $277 · 2020: $228 · 2021: $455 · 2022: $256 · 2023: $575 · 2024: $1,142 · 2025: $1,350.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,767 · Travel and Lodging: $299.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,767.30 |
| Travel and Lodging | $298.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $837.51 | 2019-2025 | Lifevest |
| Medtronic, INC. | $798.23 | 2024-2025 | Abre, Hawkone, Ffrangio |
| Janssen Pharmaceuticals, INC | $520.76 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $323.41 | 2019-2025 | |
| Shockwave Medical, INC | $323.01 | 2022-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Abbott Laboratories | $218.06 | 2022-2025 | Diamondback Peripheral, Supera, Thoratec Heartmate 3 Lvas Implant Kit |
| Astrazeneca Pharmaceuticals LP | $195.01 | 2020-2023 | Brilinta |
| Amgen INC. | $190.27 | 2019-2025 | Repatha, Repatha |
| Irhythm Technologies, INC. | $174.19 | 2023-2024 | Zio Xt Patch, Zio Monitor |
| Bayer Healthcare Pharmaceuticals INC. | $99.42 | 2021-2025 | |
| Boston Scientific Corporation | $99.10 | 2023-2024 | Avvigo Guidance System |
| Boehringer Ingelheim Pharmaceuticals, INC. | $94.78 | 2021-2025 | Jardiance |
| Inari Medical, INC. | $72.84 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Sanofi-Aventis U.S. LLC | $65.91 | 2019-2021 | |
| Stryker Corporation | $61.98 | 2025 | Flowtriever |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cardiovascular Systems INC. | $46.19 | 2022-2023 | Diamondback Peripheral |
| Cardiva Medical, INC. | $36.04 | 2023 | Cardiva Vascade Mvp Vvcs 6-12f, Cardiva Vascade 6/7f Vcs |
| Kiniksa Pharmaceuticals International, Plc | $31.51 | 2024 | Arcalyst |
| Bard Peripheral Vascular, INC. | $27.39 | 2023 | Venovo |
| Philips North America LLC | $25.18 | 2023 | |
| Pfizer INC. | $14.82 | 2019 | |
| Esperion Therapeutics, INC. | $13.09 | 2021 | |
| Medtronic Vascular, INC. | $12.41 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jasdeep Dalawari listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.